Earnings · US stocks
ImmunityBio Inc (IBRX) earnings
ImmunityBio Inc published its quarterly report on 2026-11-09. The stock moved -22.76% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-09
- Result
- Bad / loss
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -17.66% | — |
| 3 days | -22.76% | — |
| 7 days | -27.50% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 3 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +0.19%).
| Published | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|
| 2026-11-09 | -0.09 | -84.80% | -22.76% | — | — |
| 2026-08-04 | -0.22 | -175.00% | +2.38% | +13.85% | +13.88% |
| 2026-05-07 | -0.08 | -20.00% | -3.22% | -12.17% | -13.93% |
| 2026-02-23 | -0.06 | +37.93% | +9.66% | -18.62% | -14.20% |
| 2025-11-04 | -0.07 | +30.00% | +2.40% | +1.44% | +2.01% |
| 2025-08-05 | -0.10 | — | -0.21% | +16.60% | +12.03% |
| 2025-05-12 | -0.15 | -7.14% | +20.29% | +34.78% | +27.26% |
| 2025-03-03 | -0.08 | +38.46% | -6.99% | -20.06% | -9.92% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.